## FIVE: Five Below, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 2.7% below STRENGTH zone (3.0-6.0%); PEG 1.32 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($155.44)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 2, Bearish: 1)

**1. Five Below, Inc. Announces Third Quarter Fiscal 2025 Financial Results**
- Source: Licensing International | 20251204T034401 | Bullish | Relevance: 100%
- Five Below, Inc. reported strong financial results for the third quarter of fiscal 2025, with net sales increasing by 23.1% to $1.0 billion and comparable sales up by 14.3%. The company also increased its full-year 2025 sales and EPS outlook, reflecting confidence in its customer-centric strategy and positive momentum heading into the holiday season. CEO Winnie Park attributed the success to delivering trend-right merchandise, effective marketing, and engaging shopping experiences.

**2. Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf**
- Source: GlobeNewswire | 20251204T034401 | Bearish | Relevance: 100%
- Grabar Law Office is investigating potential claims on behalf of long-term shareholders of Five Below, Inc. (NASDAQ: FIVE), Molina Healthcare, Inc. (NYSE: MOH), Synopsys, Inc. (NASDAQ: SNPS), and Unicycive Therapeutics, Inc. (NASDAQ: UNCY). These investigations stem from alleged securities fraud and breaches of fiduciary duty by company officers and directors, impacting shareholders who held stock prior to specific dates. Shareholders are encouraged to contact the firm to potentially seek corporate reforms and the return of funds without personal cost.

**3. UBS Maintains Five Below (FIVE) Buy Recommendation**
- Source: Nasdaq | 20251204T190400 | Bullish | Relevance: 100%
- UBS has re-affirmed its Buy recommendation for Five Below (FIVE), with an average one-year price target of $167.20, suggesting a 2.48% upside. Institutional ownership in Five Below shows a slight increase in the number of funds, but a decrease in total shares owned by institutions over the last quarter, while the put/call ratio indicates a bullish outlook for the stock. The company's projected annual revenue is expected to increase by 9.93% to $4,866MM, although non-GAAP EPS is projected to decrease by 2.03%.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 17, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Jefferies | $215 | $185 | +16% |
| 2025-12-04 | Citigroup | $175 | $150 | +17% |
| 2025-12-04 | Truist Securiti | $179 | $168 | +7% |
| 2025-12-04 | Goldman Sachs | $188 | $162 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Jefferies | main | Buy |
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-12-04 | Truist Securiti | main | Hold |
| 2025-12-04 | Goldman Sachs | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.12M) |
| Sells | 7 ($1.99M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+1.3%)
- Blackrock Inc.: 9.1% (-5.9%)
- FMR, LLC: 4.0% (+1.7%)
- Shaw D.E. & Co., Inc: 3.8% (-28.0%)
- American Century Com: 3.4% (+21.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 17 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.32 suggests fair value with growth premium. Forward P/E 26.9x stretched relative to 6% growth. Analyst sentiment positive (17 raises, avg +10%). Insider selling cluster ($2.0M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $10.5B |
| Beta | 1.17 |
| 52W Range | $52.38 - $192.45 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.32 |
| Forward P/E | 26.9 |
| Current P/E | 28.6 |
| YoY Growth | 6.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 3.8% to 2.7% (-1.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.3pp (needs >3.0% for momentum thesis). MRS_5 at 2.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.39), confirming momentum. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.67% (CS: 78) | Neutral |
| RSI_14 | 64.9 | Neutral |
| MACD Histogram | 1.39 | Bullish |
| vs SMA20 | 1.085x | Above |
| vs SMA50 | 1.089x | Above |
| vs SMA200 | 1.377x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $168.42
- **Stop Loss:** $155.44 (7.7% risk)
- **Target:** $181.40 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $12,968.34
- **Portfolio %:** 12.97%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-03-18 (Est: $3.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.26 | $0.68 | +165.4% |
| 2025Q3 | $0.63 | $0.81 | +29.4% |
| 2025Q2 | $0.83 | $0.86 | +3.4% |
| 2025Q1 | $3.37 | $3.48 | +3.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*